India Pharma Outlook Team | Friday, 25 October 2024
Thermo Fisher Scientific signed a Memorandum of Understanding (MoU) with the Telangana Government to set up a bioprocess design centre (BDC) in Genome Valley, Hyderabad. With a total area of 10,000 sq. ft., the bioprocess design center is scheduled to begin operations in early 2025. It will act as a model to speed up the creation and production of cutting-edge biotherapeutics in India and the Asia-Pacific area. The Center will have cutting-edge laboratories and education centers to support scientific studies.
Telangana minister for IT&E, industries & commerce and legislative affairs, Duddilla Sridhar Babu, said, “The establishment of this bioprocess design centre reflects the state’s progressive policies and collaborative approach to building a robust biopharma infrastructure. With over 1,800 companies, Telangana is leading the way in making India a global hub for biopharma innovation. We partner with Thermo Fisher, the world leader in serving science, which is a transformative initiative that will advance the future of healthcare.” Shakthi Nagappan, director of lifesciences and pharma, Government of Telangana, stated, “This partnership with Thermo Fisher marks a significant milestone in our efforts to build a first-of-its-kind bioprocessing facility for biologics manufacturing in India. The centre, featuring single-use bioreactors, will enhance the biopharma sector by offering pay-per-use infrastructure, technical expertise, and cutting-edge research solutions, helping companies reduce their time to market. It will not only drive the growth of biopharma manufacturing in Telangana but also bolster India's position on the global map."